Cardiovascular drugs play a crucial role in managing and treating various conditions affecting the heart and blood vessels. These medications are designed to regulate the cardiovascular system, helping to control blood pressure, reduce cholesterol levels, and manage other cardiovascular disorders. Common types of cardiovascular drugs include beta-blockers, which block the effects of adrenaline and lower heart rate; ACE inhibitors, which relax blood vessels and decrease blood pressure; and statins, which effectively lower cholesterol levels. Additionally, antiplatelet drugs, such as aspirin, help prevent blood clot formation. The use of these medications is often tailored to an individual's specific health needs and may involve a combination of drugs to achieve optimal results. It is crucial for healthcare professionals to carefully prescribe and monitor these medications to ensure their effectiveness and minimize potential side effects. Patients prescribed cardiovascular drugs should adhere to their treatment plans, attend regular check-ups, and make lifestyle adjustments to promote overall heart health.
Title : A diabetic sweetheart facing a sour ending!
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Cardiovascular nanomedicine: Stopping strokes, unclogging arteries and restoring heart function
Thomas J Webster, Hebei University of Technology, China
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Perception of cardiovascular risk in women after a rehabilitation program
Maria Teresa Carvallo Marin, Privado, Chile